NCT04721158View on ClinicalTrials.gov

CGM Use in Children With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 17, 2021

Primary Completion Date

July 28, 2022

Study Completion Date

July 28, 2022

Conditions
Type 2 DiabetesHyperglycemia Due to Type 2 Diabetes Mellitus
Interventions
DEVICE

Continuous glucose monitor

Eligible patients will have a Dexcom G6 Continuous Glucose Monitor placed for 10 days.

Trial Locations (1)

21287

Johns Hopkins Pediatric Diabetes Center, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT04721158 - CGM Use in Children With Type 2 Diabetes | Biotech Hunter | Biotech Hunter